Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Shortened Zidovudine Regimens to Prevent Mother-to-Child Transmission of HIV Type 1

This study has been completed.
Sponsor:
Collaborators:
Harvard School of Public Health
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Information provided by:
Institut de Recherche pour le Developpement
ClinicalTrials.gov Identifier:
NCT00386230
First received: October 10, 2006
Last updated: May 1, 2008
Last verified: May 2008